JP Morgan Chase’s Nanobiotix NBTX Stock Holding History

JP Morgan Chase’s Portfolio NBTX Stock Details NBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-256	Closed	-$735	–	7595
2024 Q4	$735	Buy	+256	New	+$1.02K	﹤0.01%	6764
2023 Q3	–	Sell	-2	Closed	-$10	–	7635
2023 Q2	$10	Buy	+2	New	+$9	﹤0.01%	6817

Other funds holding NBTX

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

JP Morgan Chase's NBTX Position: Q1 2025 in Review

JP Morgan Chase sold out of Nanobiotix (NBTX) in Q1 2025, closing a stake of 256 shares — an estimated $735 sold.

JP Morgan Chase first reported a position in NBTX in Q2 2023 and held it in 2 quarters. The position peaked at $735 in Q4 2024. 12 funds tracked by Wall St. Rank hold NBTX as of Q1 2025.

JP Morgan Chase reported no remaining Nanobiotix position as of Q1 2025 after selling out during the quarter.
JP Morgan Chase sold 256 Nanobiotix shares in Q1 2025, an estimated $735.
JP Morgan Chase first reported a position in Nanobiotix in Q2 2023 and held it in 2 quarters.
JP Morgan Chase's Nanobiotix position peaked at $735 in Q4 2024.
12 funds tracked by Wall St. Rank held Nanobiotix as of Q1 2025.

Based on JP Morgan Chase's 13F filing for Q1 2025, filed 12 May 2025.